Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank You All Who Replied To My Request For Pink Current Opinions
My opinion is we will be Pink Current between the end of July to the end of August which is supported by the consensus of several of my direct colleagues.
Then in the wake of that happening (within 1-2 Weeks) I believe it is highly likely RGBP will be bought out by a Big Pharma similar to what happened to Kite Pharma that was bought out by Gilead in 2017 for $11.9 Billion in Cash.
Pre-Buy Out, Kite Pharma was a developmental stage Bio-Pharma in the same Market space as RGBP relative to their immunology based Patent(s) for treating various cancers.
At the time of their buy out, they had developed a Chimeric Antigen Receptor T-Cell Therapy (CAR-T) that harnesses the body’s immune cells to recognize and attack malignant cells. Sound familiar??
That Patent got FDA Approval and successfully passed through all stages of clinical trials (as expected with a 95% probability associated the FDA Approval itself as I previously discussed) and made it to Market as a therapeutic for cancer treatment including advanced lymphomas. At the time of the buy out Gilead's Market Value was $96 Billion.
Will history repeat itself??
This is an opinion ONLY and the later point of the Buy Out is supported by Koos filing the 8K that protects against a Hostile Take Over during buy out negotiations that most everyone here is likely well aware of by now.
Be well and prosper...
Thank you!
Be well and prosper...
Consensus Request From All RGBP Longs
I'd like to know all Long's personal opinion of when you believe this Company will become Pink Current?
i.e.
1). by end of July
2). August
3). Within first 3 weeks of September
4. Last week of September
Thank you
Be well and prosper...
Good Question Bonnie Mac!
I'm not aware any such concerns of side effects of mRNA based drugs but that will be discovered upon RGBP's Patent entering clinical trials shortly.
Phase I is about that very thing!
Be well and prosper...
EXCELLENT POST CARTER!! A SUPERB REVIEW OF THE BIOTECH SECTOR!!!
Very clearly you've done your homework.
I hope everyone here is paying attention to your post for reason it spells out what can and does happen in the Biotech sector especially related to largely "unknown" Biopharmas with no earnings and heavily in debt, BUT with a drug patent pipeline worth Billions.
RGBP has at least 20 with (1) FDA Approved Patent for (2) INDs for entering clinical trials to treat pancreatic and colon cancer...and to boot they have partnership licensing arrangements with Oncology Pharma to take that patent into clinical trials authorized by the FDA. That's an epic "game changer" for RGBP! This totally changed its perceived Market Value overnight to ALL the Big Pharmas out there.
That Patent has at least a 95% chance of passing through all 4 Clinical Trial phases and making it to Market. It is a Multi-Billion Dollar Patent with mRNA disruptive biotechnology which like Kite Pharma, makes them a prime target for Buy Out by a Big Pharma. The chances of that happening are very high...more likely than not!
Lastly, I find it very interesting and coincidental that Kite Pharma, just before they were bought out by Gilead for $12 Billion, were a developmental stage Biopharma engaged in discovery of immune based therapies to treat various cancers 100% identical to RGBP! And not only this, like RGBP, they were based in Los Angeles, California.
History repeats itself....
Be well and prosper
20/20 On RGBP's FDA Approval For Clinical Trials
Regarding my statement:
"This Patent is already in the BAG! If not, it would NOT of been FDA approved for entering Clinical Trials."
The FDA rigorously scrutinizes all Patent applications for an IND via a Medical-Scientific Board commonly referred to as an "IRB" or Institutional Review Board.
The IRB is composed of leading world class experts in their various fields, i.e. published & lectured, M.D./Ph.D. Clinician-Scientists who possess authoritative knowledge in the specific areas of each Patent Application, i.e. the relevant underlying science including the proposed clinical nuances.
Many of these professionals were involved at one time in the development of pharmaceuticals on the market today and they ALL have a broad history of publishing in peer reviewed medical/scientific journals and/or hold (or have held) faculty positions at various Medical Schools or University Graduate Programs leading to advanced degrees in the Sciences. Others have career backgrounds that have included siting on the Board of Big Pharmas and were directly involved in Intellectual Property Patent Development, i.e. Big Pharma I.P's. These are authoritative scientific professionals in their own right.
All the above is just to give everyone here an idea of who these people are that sit on the FDA Review Board for approving or rejecting INDs. I know from first hand experience throughout my 30+ Year career as an M.D. clinical trials professional involved in both the design & conduct of clinical trials as a Principal Investigator who has had extensive involvement for decades in the FDA mandated IRB Board Review Process for initiating INDs into Clinical Trials, i.e. post approval on an IND Application, and therefore I am thoroughly acquainted with scores of FDA approved INDs relative to the scientific-clinical merit of those approvals that I am required to thoroughly understand in order to design clinical trials protocols for bringing those INDs to Market. That's what the core of my professional experience is all about...bringing INDs like RGBP's NR2F6 Patent to Market via Phase 1-IV Clinical Trials the results of which must also be reported to the FDA including answering any of their inquiries.
Those experts chosen by the FDA to sit on their internal IRB possess the exact same level of scientific & clinical knowledge expertise (or greater) than the individuals who developed the Patents. Is it making sense now???
So the FDA review process is NOT conducted by one person reviewing a Patent for approval. Instead, it's a highly qualified Medical-Scientific Board.
When they vote to approve ANY Candidate Drug Patent for an IND it must be by unanimous vote and IF that doesn't happen the Patent is rejected for entry into Clinical Trials!!!
This is the reason why only about 1 in 10,000 Patent applications for an IND get approved by the FDA for entering clinical trials, meaning they are near 100% certain that the extremely limited number of Patents they approve will more than likely transition successful through all phases of clinical trials and will be effective pharmaceuticals for various treatment applications.
Sometimes these FDA-IRB reviews can last for several months and in some cases years via multiple re-submission IND requests with further validating information to support the Patent requested by the FDA Board.
During this process they're known to send a battery of written requests for clarification of various areas of the underlying science that can extend to questioning the methodologies that the science was derived from, and even the various statistical models utilized in data analysis that should be based on linear regression.
It is an extremely rigorous lengthy process that results in MOST Patent Applications for an IND being OVERWHELMINGLY REJECTED!!!
This is the reason why only about 50 Patent Applications to the FDA for an IND out of 10,000 make it to Market. Importantly, this estimated number (50), represents about 95% of the Patent Applications that received FDA Approval to enter Clinical Trials like RGBP. It's almost the equivalent of hitting the LOTTO!!!
The take away:
The possibility of RGBP passing successfully through ALL Clinical Trial Phases (I-IV) and making it to Market is HIGHLY PROBABLE!! It's at least a 95% probability! If NOT, it would of never been approved by the FDA for Clinical Trials from the GET GO!!!
I hope this information helps dispel doubts from naysayers about what this company has and reveals the extraordinary success made by RGBP in getting FDA Approval on their NR2F6 Patent for Clinical Trials; something that happens next to NEVER!!!
My advice??? KNOW WHAT YOU OWN!!! In this case it's a Gold Mine for which the current PPS trading range for months has absolutely nothing whatsoever to do with. It's is a function of Market Manipulation.... nothing more, and that manipulation is in its last hour beginning with Pink Current.
On the horizon after that... OTCQB then NASDAQ.
Lastly IMO, what should of happened with this company from the beginning is open on NASDAQ as an IPO. That could of easily been done with the caliber of Patents RGBP owns, all of which represent Disruptive Biotechnology.
Disclaimer: All the above is a personal opinion only but one that's drawn from decades of professional experience.
Be well and prosper...
RGBP Will Surpass ENZ*C Run To $1.00
ENZ*C ran to nearly $1 in February within 19 days of going PINK CURRENT!
RGBP will do FAR BETTER and here's WHY
ENZC had:
#1 (1) Patent only
#2 No FDA approval
#3 No licensing arrangements
#4 No partnerships
#5 No catalysts
#6 No PR releases
#7 No prospect of revenue (due to #2 & #3)
#8 No suggestion of Buy Out by CEO
RGBP has:
#1 20+ Patents worth $BILLIONS
#2 Licensing of (1) Patent with (2) INDs (New Drug Applications) for treating pancreatic & colon cancer by mRNA Vaccine-"The Future of Medicine"
#3 Recent PR of FDA Approval for Clinical Trials
#4 Partnership: Received up front payment from Oncology Pharma for Patent Licensing; is NOW positioned to receive Quarterly Revenues for 15 YEARS!
#5 Going Pink Current within weeks = Instant buying capacity on dozens of brokerage platforms!
#6 CEO suggests Buy Out by filing an 8K to protect against a Hostile Take Over that specifically states "negotiations must be made direct" (in reference to himself).
IMPORTANT NOTE RELATIVE TO #4: Oncology Pharma closed yesterday 7/9/21 at $27.39 UP $2.29. On June 30th they issued a News Release the focus of which was their licensing of RGBP's NR2F6 Patent coupled with their proprietary drug delivery systems for treating various disorders including pancreatic cancer and colon cancer.
https://finance.yahoo.com/news/oncology-pharma-inc-entering-next-120000837.html
In retrospect, Oncology Pharma acquired RGBP's NR2F6 Patent on April 7, 2021. The prior trading day (April 6th) its PPS was $24.99. On April 7th their PPS jumped to $26. Subsequently, their PPS began rising DAILY throughout April hitting $40.37 on April 29th, UP $15.38 relative to their immediate pre-acquisition date (April 6th) of RGBP's Patent.
The take away?? Upon a PR release of RGBP's Patent officially entering Phase I Clinical Trials, that by itself should cause the PPS of BOTH RGBP & Oncology Pharma to jump and begin a steady consistent rise.
Subsequently, any positive PR releases of its progress, including transitioning into Phase II-III, will predictably cause their PPS to continue rising. Just look at how Oncology Pharma's PPS began a steady rise immediately AFTER the news that they acquired RGBP's Patent. There's a reason for this by "those in the know" of what that means.
Keep in mind that by the time of the final phase of Clinical Trials (Phase IV), the candidate drug has already received FULL FDA approval for use in the general population relative to its intended treatment applications. Phase I-III is for efficacy & safety testing only. Phase IV is for drug branding (name selection) and post-marketing surveillance and at that point it is already being prescribed by physicians and administered to patents.
My Point??? This Patent is already in the BAG! If not, it would NOT of been FDA approved for entering clinical trials. WHY? Only 1 in 10,000 Patent applications for an IND get approved by the FDA for entering clinical trials, meaning they are near certain that the limited few they approve will likely transition successfully through all Phases and will be effective pharmaceuticals for disease treatment.
Statistically, less than 50 Patent Applications to the FDA out of 10,000 make it to market annually.
This information arises out of my 30+ Year career as an experienced Clinical Trials M.D. that has worked with several Big Pharmas in bringing their candidate drug Patents to Market.
I hope all the above is helpful to those in this play and/or are considering investing in RGBP.
Be well and prosper...
WHY RGBP Will Do Far Better Than ENZ*C WEEKS From NOW!
ENZ*C ran to nearly $1 in February within 19 days of going PINK CURRENT!
At that time:
ENZC had:
#1- (1) Patent only
#2- No FDA approval
#3- No licensing arrangements
#4- No partnerships
#5- No catalysts
#6- No PR releases
#7- No prospect of revenue
#8- No suggestion of Buy Out by CEO
RGBP has:
#1- 20+ Patents worth $BILLIONS (several currently being reactivated)
#2- Licensing of (1) Patent with (2) INDs (New Drug Applications) for treating pancreatic & colon cancer by mRNA Vaccine, i.e. "The Future of Medicine"
#3- Recent PR of FDA Approval for Clinical Trials
#4- Partnership with Oncology Pharma (last traded at $25.10 on 7/8/21): Received up front payment for Patent Licensing and is NOW positioned to receive Quarterly Revenues for 15 YEARS!!
#5- Going Pink Current within weeks = instant buying worldwide on dozens of brokerage platforms!
#6- CEO suggests Buy Out by filing an 8K to protect against a Hostile Take Over that specifically states "negotiations must be made direct" (in reference to himself only).
BONUS Post-Pink Current
#1- Possible Uplisting to OTCQB
#2- Possibility of Institutional Investors Buying-In Post Uplisting.
What more could anyone want on the OTC?? TOTALLY UNHEARD OF!!
Enormous buying pressure will predictably set in Post-Pink Current like it did for ENZ*C that should send the PPS to $1.00 and beyond based on the above comparative FACTS!!!
The "Take Away?" RGBP's current Market position is far greater than ENZ*C's was back in February when it made its run...a NO BRAINER!!!
Very likely a repeat performance only greater!
Personal opinion only but one that makes common sense.
Be well and prosper...
HOW HILARIOUS!!!
I CAN'T STOP LAUGHING!!!
What needs to be "looked into" is YOUR HISTORY!!
LOL!
No One Said Anything About ENZ*C Not Succeeding!
MrTrader Joe:
I was ONLY making a comparison, nothing more!
ENZ*C is a great play also with enormous Market potential and I was in that play with several million shares and did very well!
RGBP however, like I outlined, very clearly has A LOT MORE going for it and is much further along in its natural development which is undeniable!
Be well and prosper...
The Bigger Picture Says It All!
RGBP has more than ample time to become Pink Current which Koos has professionals currently working on evidenced by all the 8-Ks that have been appearing recently.
https://www.otcmarkets.com/stock/RGBP/disclosure
SEC FILINGS
TYPE RECEIVED PERIOD
8-K 7/02/2021 6/16/2021
8-K 6/30/2021 6/28/2021
8-K 6/28/2021 6/28/2021
10-K 6/21/2021 9/30/2019
8-K 6/01/2021 6/01/2021
8-K 5/13/2021 5/12/2021
8-K 5/07/2021 5/07/2021
8-K 4/27/2021 4/23/2021
8-K 4/21/2021 4/21/2021
8-K 4/19/2021 4/19/2021
8-K 4/16/2021 4/15/2021
8-K 4/09/2021 4/08/2021
8-K 4/08/2021 4/07/2021
8-K 3/30/2021 3/26/2021
8-K 3/25/2021 3/23/2021
Lastly your comment:
"the SP will be heavily manipulated by the MMs and shorts and other large groups/retail to get in cheap, like we saw the wild swings for ENZC."
Yes, while that may be true, which everyone here is well aware of, you forget one important detail.....
Upon Going Pink Current:
#1- Scores of Brokerage Firms instantly become available for investors to buy this stock Worldwide that will result in enormous upward pressure on the PPS that definitely offsets MM manipulation.
#2- It's also very likely Institutional Investors will move into this stock as well and they are known to drop millions upon million of dollars into any stock they target. With that kind of buying pressure combined with global buying by retail investors worldwide, it is more than sufficient by far to offset MM manipulation.
Recently I saw this happen to a Bio-Pharma that ran 500% in a single trading session due to enormous buying pressure that blew away MM manipulation...it ALWAYS DOES!!!
One thing I've learned about MM manipulation is they can't cope with enormous buying pressure!
Thank you again for your comment.
Be well and prosper...
Your Analysis is "Logical" BUT Not Reality Based
You said "these things don't run quickly." Oh, they don't??? Are you sure??? Let's take a look at that!
Apparently you're not aware that ENZ*C ran to nearly $1.00 in January this year within 19 trading days of going Pink Current with NO Catalysts whatsoever, No PR, No "big licensing deal" (in fact none at all), No clinical trials to "prove their biotech", and they had been trading in the sub-penny and penny range for an extended period of time.
Now let's objectively summarize the FACTS when this happened:
ENZ*C had:
#1 1 Patent only
#2 No FDA approval
#3 No licensing arrangements
#4 No partnerships
#5 No catalysts
#6 No PR releases
#7 No revenue whatsoever
#8 No suggestion of a Buy Out by the CEO
RGBP has:
#1 20+ Patents
#2 Active licensing of 1 Patent that has a Multi-Billion Dollar Market Capacity for treating pancreatic & colon cancer
#3 Recent PR release of FDA Approval to enter clinical trials
#4 Is revenue generating
#5 Is about to go Pink Current within weeks
#6 CEO clearly suggests a possible Buy Out by filing an 8-K in April to protect against a Hostile Take Over and specifically states "negotiations must be direct" in reference to buy out offers being made with himself only independent of his Board.
In contrast to the above:
In December 2019 between 12/12/19 to 12/31/19 the Bio-Pharma Cytodyn ran from 0.28-to-1.00 in only 13 trading days with no catalysis whatsoever. Within 12 months time it hit a 52-week high of $10.00 having only 1 Patent that got FDA approval to enter clinical trials. SOUND FAMILIAR???
Cytodyn at that time had:
PINK CURRENT
1 Licensing deal
No Revenue
No PR other than FDA approval to enter clinical trials 100% identical to RGBP!
So although your perspective is appreciated, it is NOT reality based.
PINK CURRENT predictably is going to send RGBP's PPS to $1.00 which is a high probability. WHY? Multiple Brokerage platforms become immediately available for trading worldwide which is exactly what happened to ENZ*C within 19 trading days of going Pink Current despite having no where near what RGBP has.
So much for your Hypothesis!
Disclaimer: PERSONAL OPINION ONLY...ONE THAT MAKES COMMON SENSE
Be well and prosper...
IT'S ALL GOOD NOW!!! UP FROM HERE!!!
Train leaving station DON'T get left behind!
20+ Patents (Disruptive BioTechnology)
1 Licensed Patent FDA APPROVED!!
Revenue Generating
Possible Big Pharma Buy Out LOOMING!
What more do you want in ANY OTC???
Well said!
Great analysis as always!
Be well and prosper...
Well Said!
I see your point, great perspective!!
The sum of the parts is greater than the sum of the whole!
I agree 100%
Listen, Koos is very smart, a classic strategist, and no doubt in the back of his mind he's definitely aware of your analysis.
If it plays out the way you elegantly described no doubt he'll get the $MAX$ via the equivalent of throwing rib eye steaks to a pack of hungry wolves!
Let's all remember the 8-K he filed in April puts him in total control as the "Shot Caller" in a Buy Out-Merger Acquisition scenario! It seems to me that's what he's preparing for; if not filing that 8-K was meaningless!
We will soon see.
Be well and prosper...
EXCELLENT POST!
The best explanation yet!
Thanks
Good Question!
Anyone's guess but I perceive IF a Buy Out-Merger Big Pharma Acquisition occurs RGBP stock holder's shares will be trading at the current PPS of the acquiring Company BUT with fewer shares. It depends on what the "per share" buy-out arrangements are.
It's important to keep in mind however that upon a Buy Out-Merger Acquisition the acquiring company will own ALL of RGBP's 20+ Patents Plus the current one that just got FDA approved to enter Clinical Trials. That by itself makes RGBP even more attractive as a Buy Out candidate for reason the acquiring company can immediately put that IND in its own clinical trials pipe line.
Due to its extensive portfolio of Disruptive Biotechnology Patents, the intrinsic valuation of RGBP is astonishing easily well into the Mega Multi-Billion Dollar range. The current Patent going to clinical trials soon has a global market capacity in the Multi-Billion dollar range by itself!
Therefore, the PPS buy out PER SHARE, again IF that occurs, could be in the dollar range with all things considered.
This of course is my personal opinion only.
Be well and prosper...
Regarding Recent FDA Approval - Commencement of Clinical Trials
...the first step toward globalization of RGBP's NR2F6 Patent for treating pancreatic & colon cancer.
KCL Therapeutics, Inc.(“KCL”), a wholly owned subsidiary of Regen Biopharma Inc (the “Company”), was informed by the United States Patent & Trademark Office (USPTO) that Patent Protection shall be granted to KCL with regard to “Methods and means of generating IL-17 associated anti-tumor effector cells by NR2F6 inhibition.
Chairman/CEO David Koos noted:
#1- "Checkpoint inhibitors are a new class of drugs that include Ipilimumab (Yervoy® Bristol Myers Squibb; 2018 estimated sales of $1.5 Billion1), and Pembrolizumab (Keytruda® Merck, 2017 sales of $3.4 Billion."
#2- "Current checkpoint inhibitors act to augment immune responses but do not have direct anticancer effects."
#3- "By creating approaches to inhibit NR2F6 the Company aims to develop a new class of Checkpoint Inhibitors that concurrently block tumor growth while enhancing the immune system."
F.Y.I. YOU'RE WITNESSING THE FUTURE OF MEDICINE IN PROGRESS VIA THIS SINGLE MULTI-BILLION DOLLAR MARKET CAPACITY PATENT OF WHICH RGBP HAS MANY!!! (20+)
Be well and prosper...
WoW!! I'm Impressed!
Music to my ears...
Spoken like a Clinical Trials Professional!
Though I'd never see it here!
I concur 100%
Yes indeed we have been cleared by the FDA which of course is the 1st step in opening (or reactivating in our case) an IND and this time it's going to FLY!
Transitioning into mRNA Clinical Trials fundamentally puts RGBP in the same category as any Big Pharma pursuing development of a candidate drug for commercialization! The applications are broad, ours addresses the treatment of pancreatic & colon cancer.
Now I fully understand why Koos filed that 8K that protects against a Hostile Take Over for reason he knows one or more Big Pharmas are going to come knocking on his door soon seeking to Buy this company from under him so they can Put our IND in their pipeline as well as own ALL our other Patents and file for INDs on several of them as well, thus his reason for making a move to revive many of them .
LET THERE BE NO MISTAKE ABOUT IT...THIS IS A MULTI-BILLION DOLLAR PLAYING FIELD WE'RE ON AND ULTIMATELY IT'S A SET UP TO A BIDDING WAR FOR RGBP!! Koos knows this thus his reason for filing that April 8K that keeps him in control of bidding negotiations...he even specifically states this in the 8K! i.e. "must negotiate directly" referring to himself
The Plot is thickening..
RGBP unequivocally is a Bio-Pharma Gold Mine owed to its extensive Disruptive Biotechnology Patents that Big Pharmas "kill for"!!!!
Many of you don't know this but the Big Pharma Industry as a whole can best be characterized by the words "Vicious" & "Cut Throat" and that has to do with staying ahead of the competition at ALL cost as well as Market Domination.
Microcaps like RGBP are definitely on their radar to snap up before their competitor.
I strongly believe a Buy Out if forthcoming and that it's just a matter of time. Possibly within a six months or less of going Pink Current.
This is only a personal opinion although it is a qualified one and I don't claim to be Nostradamus.
Be well and prosper...
Thank You My Good Friend!
It's delightful to hear from you!
All is well with RGBP and it will rise to great heights and the same applies to our original play!
Just a matter of time!
Let's connect privately soon!
Best wishes
It's Flattering To See My "Word-for-Word" Writings On Microcap Daily!
Apparently they like my scientific writing skills!
Although it qualifies as plagiarism I'll let it slide! LOL!
Be well and prosper...
Good Question
I don't know for certain but you can email him and ask him. He's known to return email inquiries.
May be another poster here can answer that question as well. Simply create a post with what you stated in the title.
Explosive Growth Straight Ahead! Be Prepared!
Between NOW and going Pink Current within weeks we can expect strong momentum moving in that will send the PPS to new 52 Week highs....there will be MANY!!
Post-Pink Current...ALL STOPPERS PULL OUT!!! FULL IGNITION!!!
Dozens of brokerage platforms immediately become available to buy RGBP worldwide! i.e. the "investment pool" suddenly changes from a pond to an ocean!
I fully expect a PPS North of $1.00 in the near term wake of Post Pink Current and I believe this is a conservative estimate although it could be higher, and this is ONLY an opinion that I believe is by far a reasonable one.
ENZ*C hit nearly $1 within 19 trading days of going Pink Current despite it having only 1 Patent with no licensing arrangements, no partnerships, not on the verge of entering clinical trials, and no prospect of generating revenues. There's no comparison by far to RGBP's intrinsic value tied to its extensive Multi-Billion Dollar Patent portfolio and current Market position.
20/20
Strong fundamental changes have recently set in for RGBP significantly contributing to its evolution and there will be many more to come.
Recently becoming a revenue generating Bio-Pharma that has successfully licensed 1 of its 20+ Patents, each representing "Disruptive Biotechnology" and each with a $$Billion Dollar market capacity, is just one new development for RGBP now in play.
The near term transition of this new development is RGBP's Candidate Drug Patent NR2F6 for treating pancreatic & colon cancer soon to enter Phase-1 Clinical Trials.
https://www.stocktitan.net/news/ONPH/oncology-pharma-inc-is-entering-into-the-next-phase-of-its-growth-msgem1hjj0hb.html
This development substantially strengthens RGBP's Market Capacity profile marking it as a strong candidate for a Big Pharma Buy Out or Merger-Acquisition that is very common for a Bio-Pharma Company our size and no doubt Koos is aware of this due to him filing the 8K this past April that protects against a Hostile Take Over. IMO, He's likely going to need it!
This is an evolving Bio-Pharma presently in its embryonic stages of development that begins with "PATENT DISCOVERY-THE SCIENCE OF IT ALL", just like ANY Big Pharma on the market today was at one time that also went through the exact same evolution. For those who didn't know this now you do and this is a qualified clinical trials M.D. perspective!
There are very few IF ANY developmental stage Bio-Pharmas in existence on any Stock Exchange that have anywhere close to what RGBP has, and if so, I'd like to know who they are so I can invest in them!
Best wishes to all, and again the above is a personal perspective and opinion only but with professional industry experience insight.
Be well and prosper...
AMEN!
YOU GOT THAT RIGHT!!!
LOAD & HOLD...
LONG & STRONG...
KNOW WHATCHA' GOT
Be well and prosper...
AMEN!!!
I concur!
We are witnessing the birth of a Disruptive Bio Pharma stock similar to ENZ*C only further along with a much bigger market capacity!
Keep in mind RGBP has 20+ Patents and ENZ*C has only 1, and that's not bad by any means because it's an important Patent that holds the key to curing most strains of HIV.
RGBP on the other hand addresses a much larger playing field with its 20+ patents that are also Disruptive Biotechnology that may hold the key to curing both pancreatic & colon cancer that historically are near impossible to treat with current therapeutics.
Also RGBP is very likely a Buy Out candidate by a Big Pharma even in its early stage of development and it's 20+ Patents are a big part of that reality.
Much more could be said but I'll stop here...
LOAD & HOLD...
Be well and prosper...
Got it! Thanks!
My estimate is at least $1.00 within weeks of going Pink Current like what happened to ENZ*C, keeping in mind that unlike ENZ*C, RBGP has a licensed patent in play that just got FDA Approval for entering Phase-1 Clinical Trials and is now officially a revenue generating company, so it should do very well both short and long term.
By end of this year, I expect to see a PPS North of $1.25 and I believe I'm being conservative with this estimate. Keep in mind the Market looks mainly forward which is what trading at multiples of actual earnings is about on the Major Exchanges.
If RGBP get's bought out by a Big Pharma along ALL of its 20+ Disruptive Biotechnology Patents, including the current one soon to enter clinical trials, I believe an offer will come in at $1.50 to $2.50 per share, if not it would likely be very close to this, AGAIN keep in mind the Multi-Billion Dollar Market Capacity of all the Patents combined this company holds and Koos is right now in the process of reviving many of them likely preparing to sell the company IMO as this would be a major "shoe in" for any Big Pharma for reason as such patents would go directly into an acquiring Big Pharma's clinical trials pipeline putting them way ahead of the competition! This requires investors in this sector to adopt the mind set of how leadership at Big Pharma's think, and I'm telling you and everyone here this is precisely how ALL of them think!
The BIG PICTURE HERE IS there's simply is NO BioTech/BioPharma Company on any Stock Exchange that has what this company has, not by a long shot and if so, I'd like to know who??
Again, all the above is only my personal opinion but I believe it is a qualified one due to me being a career clinical trials Physician for more than 30+ years that has seen what can and does happen when technology like this is development and transitions into the clinical trials phase and beyond!
RGBP is following the same pattern as any Bio-Pharma in its early development, and to me this means it's just a matter of time before they get bought out by one of several Big Pharmas that are known to be "cut throat" competitive with each other with a prime directive to own Patents of other Companies worth Billions and ANY small company like RGBP that's "Patent Rich" is the exact type of company that get's bought out by one of the majors who have Billions to spend. I'm just saying, that's all as this is a very typical senario that I have seen play out MANY TIMES in my career only RGBP has more Patents to their name than I have ever seen previously for a company of their size. It's absolutely astonishing what they have and the sector they are in with their mRNA biotechnology which is very clearly the future of medicine.
I hope this helps...and it's only an opinion!
Be well and prosper....
"PT"
Please be more specific.
Thanks
IT'S STARTED!!!
UP FROM HERE ALL THE WAY TO PINK CURRENT & BEYOND!!!
Licensed Patent for treating pancreatic & colon cancer officially approved by FDA which means Phase-1 Clinical Trials straight ahead!
BUY HARD AND STRONG AT THE CURRENT DISCOUNT ...YOU'LL BE GLAD YOU DID!
I AM and have been for a very long time..SEVERAL MILLION SHARES!!!
RGBP made me $25,000.00 richer today! Drop in the bucket no biggie compared to what's coming! LOL!
mRNA Disruptive Biotechnology The Future of Medicine is the name of THIS TUNE!! GET IT???
Be well and prosper...
Ok Bonnie Mac Great To See You Back!!
Let's hook up again!
Cheers!
Talk with you soon!
Be well and prosper!!!!!
HEY...HEY...HEY...IT'S ALL GOOD NOW!!!
....AND THIS IS JUST THE BEGINNING!!!
Just think what's going to happen when we go Pink Current within WEEKS from now!!!
KAAAAAABOOOM!!!
The PPS will no doubt explode to all new heights due to a massive influx of New Buyers World Wide aggressively buying this stock on scores of brokerage platforms!
Other words, BUYING RGBP will suddenly open up to the entire world, i.e. throughout America, South America, Asia, Africa, Europe, YOU NAME IT!! LOL!
Nothing like being in the right place, the right stock, at the right time!!!
Be well and prosper...
Well Said! Your Take On That Is Actually Very Possible
...and this of course is based on that 8K that Koos filed back in April that gives him full control of Buy Out Negotiations without risk of a Hostile Take Over!
There was NO other purpose nor reason for him to file this, so YES that scenario is DEFINITELY "in the cards!"
Only question is IF he sells the Company what will be the Buy Out Price and the acquiring Big Pharma?
I also believe that a PPS offer you mentioned of $1.50 to $2.50 is very reasonable based on the 20+ "Disruptive Biotechnology" Patents this company holds with at least one of them having been licensed out recently thereby officially making RGBP a revenue generating company in the Pancreatic & Colon Cancer Treatment Space soon to enter Phase-1 Clinical Trials. A PR was released about this just a few days ago.
https://www.stocktitan.net/news/ONPH/oncology-pharma-inc-is-entering-into-the-next-phase-of-its-growth-msgem1hjj0hb.html
I perceive that RGBP is definitely on the RADAR of several Mid-Cap to Large-Cap Big Pharmas who's mouths are probably salivating waiting to grab this company, and some would likely do this for no other reason than to OWN OUR PATENTS and of course place several others in their Clinical Trials Pipeline!
I believe the waiting period for RGBP to rise to all new heights is straight ahead and that the probability of a Acquisition-Merger is at least 50% or higher IMO.
ALL Longs had best LOAD TO THE MAX while you still can at the current deep discount PPS BEFORE September 25, 2021 STRAIGHT AHEAD if anything more than reason we're going PINK CURRENT within weeks that will open the doors for a massive wave of Millions of new investors worldwide ability to BUY this Stock on scores of brokerage platforms!!
Be well and prosper...
Turning The Corner - Game Changer Coming!!
PINK CURRENT IS THE NAME OF THAT TUNE FOR STARTERS!!!
Not only this, the following factors need to be taken into consideration for reason we are entering a "New Day" in the OTC Market.
#1- presently there are NO Cavet Emperor stocks quoted on the OTC. They have all been eliminated by the SEC. There were at least a 1,000 or more.
#2- based on the above, this means that individuals who invested in those stocks who wish to remain in the OTC Market must now look to other OTC stocks that are SEC compliant. By definition this means Pink Current by Sept 25, 2021. No doubt, many more OTC stocks will fall off the OTC that are not compliant by this deadline, possibly hundreds if not thousands. There are presently at least 10,000 stocks trading on the OTC. (Google Search says 10,000 to 12,000)
#3- based on all the above, the OTC Market is shrinking relative to the number of stocks available to trade or invest in by the end of September 2021 moving forward. The result will predictably create an opportunity for buyers to pour money into the remaining Pink Current Stocks where next to none are revenue generating in a high demand sector like RGBP. IMO, this will raise the stakes for RGBP being a stock in the cross hairs of a whole new wave of investors post-Pink Current. This could cause a substantial rise in RGBP's PPS both short term and long term.
#4- With the above changes it is my belief that the investment community at large will begin perceiving the OTC as a viable alternative to NASDAQ stocks.
Other positive factors include:
#5- Presently less than 30% of OTC Stocks are Pink Current. This will significantly increase post-Sept 2021 to ALL OTC Stocks being Pink Current. Predictably as a result, more investors will flock to the OTC Market which could have a significant stabilizing effect overall with less volatility and perceived risk combined with more aggressive price action in several OTC stocks.
#6- Historically, 80% of the time positive returns on the OTC occur between September-to-March (this was clearly seen last year from Sept onward until at least early Feb)
#7-The Top 100 OTC Performers on the average return 700% on Investment within 16 months out performing ALL the other Stock Exchanges.
FACT NOT FICTION!!!
The Take-Away??
NOW IS THE TIME TO BE LOADING RGBP LIKE IT'S GOLD!!!
DO IT BEFORE PINK CURRENT DEADLINE 9/25/21 WHILE THE PPS IS AT A DEEP DISCOUNT!!!!
You'll be glad you did.
ALL the above is ONLY an Opinion.
Be well and prosper...
AMEN! GREAT MOVE!!!
ALL Longs should be engaged in a BUYING FRENZY at these deep discount prices like there's no tomorrow going to us going Pink Current within WEEKS from Now!!...keeping in mind that RGBP is Officially a REVENUE GENERATING COMPANY!!!....HELLO!
When we hit Pink Current, WHOLE NEW BALL GAME!!! Dozens of brokerage platforms allowing BUYING of this stock for Millions of Investors who are not yet in this play BUT they will be!!!
Then there's the reality of a possible Buy Out-Merger Acquisition that everyone should be aware of by now!!!
BUST A MOVE NOW!!!
Be well and prosper...
RGBP's NR2F6 Patent Entering Next Phase Toward FDA Approval
https://www.stocktitan.net/news/ONPH/oncology-pharma-inc-is-entering-into-the-next-phase-of-its-growth-msgem1hjj0hb.html
SAN FRANCISCO, CA /June 30, 2021 / Oncology Pharma Inc(the "Company") is developing a program to establish the use of its license utilizing NR2F6 agonists and antagonists coupled with the proprietary drug delivery systems in the treatment of various disorders including human pancreatic cancer and colon cancer.
The work the Company is contracting to conduct is intended to do pre-clinical trials leading into seeking FDA approval for the combined efforts.
Our team of industry experts and advisors have the expertise to lead the Company to efficiently conduct this next phase of development. The developing program will allow Oncology Pharma to begin its own path towards producing proprietary intellectual property,for the pursuit and development of new therapies.
The Company's established portfolio of licensing agreements is expected to allow the company the ability to develop its own innovations to stand out amongst its peers.
Sounds like we're on the right track and this is only the beginning as several or our other Patents are being revived by Koos.
Keep in mind RGBP is now officially a revenue generating company via the closure of its licensing deal with Oncology Pharma, totally unheard of anywhere on the OTC!
Just wait until the Quarterly Revenues begin to fall to our bottom line Q over Q.
Be well and prosper...
May I Add To Your List...
#37 - 52.91% Insider Ownership
https://finance.yahoo.com/quote/GRST/key-statistics?p=GRST
Great summary!
Be well and prosper...
It's Great Being Invested In A Disruptive Biotechnology Company!
...that has over 20 Patents each having a $$Billion Dollar Market Capacity inclusive of mRNA science which is definitely the FUTURE of Medicine here to stay for decades to come!
This has to do with transforming deadly incurable diseases into being curable and/or easily manageable.
Don't be fooled by the clever MMs holding the PPS down for months to years attempting to PSYCH YOU OUT!!!..and the ONLY reason for this of course is so that they, and ALL their GREEDY Cronies, can massively accumulate shares on the CHEAP hoping that unsuspecting investors will sell off out of fear AND at a loss, thereby giving ALL their shares away to them!
One of these days REAL SOON NOW this story is going to DRAMATICALLY CHANGE just as soon as we go Pink Current within weeks from now and THAT will be only the beginning which will include Up listing to OTCQB and/or possibly a Buy Out-Merger Acquisition with a Big Pharma, AND addition licensing of our 20+ Patents!
TOTALLY UNHEARD OF FOR ANY OTC COMPANY!!!
You're patience is about to reward you in a BIG WAY straight ahead!!!
...AND keep in mind that RGBP is officially a revenue generating compny which means quarterly revenue is going to hit the company's bottom line moving forward Q over Q!
YOU COULDN'T BE IN A BETTER PLACE AT A BETTER TIME ANYWHERE ON THE OTC!!
Patience will reward the WISE!
IMO, accumulate as often as you can while you can at these deep discount prices that are soon to be history!
Be well and prosper....
IT'S ALL GOOD NOW!!! 6-30-21 News Release!
Great post!
Be well and prosper!
Thanks Again! It's All Good!
I also appreciate ALL your highly valuable posts as a major contributor to this Forum.
...and thank you again for clarifying to me the matter about Koos absence as CEO but now back! This in and of itself dramatically raised my confidence in where we are right now moving forward, and that new 8K he just dropped was the "icing on the cake", as it clearly revealed he's working as fast as he can get get everything up to speed so this company can begin rising to a value level where it should of been a long time ago.
Thanks and God bless!
Be well and prosper...
Thank You For That...
I was not aware of Koos absence as CEO for 20 Months.
BUT nevertheless, the 20/20 key "take away" of my post is it appears that based on ALL his recent actions he's preparing to sell the company.
THAT was and is my Key POINT AND I also acknowledged all his great accomplishments.
Look, I'm vested several MILLION SHARES in this company at substantial capital outlay enough to pay cash for a 2021 BMW and I would not of done that unless I fully recognized and believed in everything this man has accomplishments, and being the clinical trials physician that I am, my natural mind set is to acknowledge other professional in this industry for their major contributions... so you "Common now" 20/20
Thanks for elightening me about Koos AND Please chill.
Be well and prosper...
20/20 On Koos - The Destiny of RGBP
What I'm about to say should not be taken as a put down to Koos for reason he has accomplished A LOT in his life time and can be viewed as a leader in emerging Biotechnology with all the Patents under his name.
BUT I perceive at this stage in his life at his age, now in his 70s, he wants to CASH OUT and move on enjoying the fruits of his labor and leave all these Patents to younger people at a Big Pharma who develop Patents for a living via clinical trials that requires a tremendous bank roll that only well established Big Pharmas have, extensive scientific support and man power, AND most of all extraordinary time & energy expenditure. I am well acquainted with ALL of this for reason I'm a career Clinical Trials Physician that has worked with several Big Pharmas throughout the U.S. over my 30+ years in this industry.
So I am well in touch with what ALL of this takes that's WAY MORE than most people can imagine who haven't worked in this industry.
The fact Koos has allowed these important Patents to expire and remain dormant all these years AND ALSO him remaining habitually delinquent in filings year-over-year is a blaring sign IMO that he simply wants to move on with his life, and there's nothing wrong with that.
IMO all the above combined with the following key recent developments seem to point to a possible Buy Out:
1). the 8K he filed that gives him full control of buy out negotiations with hostile take over prevention.
2). suddenly moving to revive several of his Patents.
3). rushing to get SEC compliant by hiring a professional auditor.
4). the extensive 10-K he just dropped.
Based on ALL these factors combined there's no doubt in my mind he's about to Sell the company. I could be wrong but all of these factors seem highly indicative of this. If not then WHAT??? Why all the sudden and aggressive action on his part after all these years beginning with an 8K filing that this gives him full power over buy out negotiations with no risk of hostile take over?? WHY???
All feedback welcome and this is ONLY an Opinion, nothing more.
Be well and prosper...